MINNEAPOLIS--(BUSINESS WIRE)--Dec. 10, 2012--
Piper Jaffray (NYSE: PJC) is pleased to announce the addition of Dr.
Charles Duncan as managing director and senior research analyst in its
biotechnology research platform. He will be based in the firm’s New York
office, focused specifically on small- and mid-cap emerging growth
biotechnology companies.
Duncan brings more than 17 years of sell-side experience, most recently
serving as an analyst at JMP Securities since 2002, and previously at
Dresdner Kleinwort Wasserstein, Vector Healthcare Group - Prudential
Securities, Tucker Anthony Cleary Gull and Chatfield Dean & Co. Duncan
has been recognized by industry sources, including the StarMine Analyst
Awards, as being among the best analysts for his fundamental and timely
analysis.
"Piper Jaffray is highly committed to further advancing its market
leading position in specialty areas of healthcare, including
biotechnology. Charles adds experience to an already well-established
platform, now with a total of four senior analysts and a significant
coverage footprint across specialty pharmaceuticals and biotechnology
sectors,” commented Jeff Klinefelter, global head of equities for Piper
Jaffray. “The firm will continue to focus efforts on providing growth
companies with strategic alternatives for funding, while offering
investors opportunities to participate in early-stage growth in exciting
areas of drug discovery."
Duncan began his career as a manager of clinical development at Global
Drug Development, Inc., a pharmaceutical development consulting firm
where he also launched InfusionVision Medical, a venture-backed start-up
medical device company. He is a graduate of the University of Wisconsin
and holds a doctorate in neuropharmacology from the University of
Colorado.
Piper Jaffray has a total of 30 senior research analysts located
in Minneapolis, New York, San Francisco and Chicago. The firm provides
coverage on 565 companies globally in key sectors: business and
financial services; clean technology and renewables; consumer;
healthcare; industrials; and technology, media and telecommunications.
About Piper Jaffray
Piper Jaffray is a leading investment
bank and asset management firm serving clients in the U.S. and
internationally. Proven advisory teams combine deep industry, product
and sector expertise with ready access to capital. Founded in 1895, the
firm is headquartered in Minneapolis and has offices across the United
States and in London and Zurich. www.piperjaffray.com
Since 1895. Member FINRA, NYSE and SIPC.
© 2012 Piper Jaffray & Co.
Source: Piper Jaffray Companies
Piper Jaffray Companies
Pamela Steensland, +1 612-303-8184
